Yoko Hashimoto is a seasoned professional in the pharmaceutical industry, currently serving as the Director and Project Leader for Late Development Oncology at AstraZeneca since 2022. They accumulated extensive experience at Novartis from 2011 to 2017, where they held various positions including Japan Program Head for Oncology Development. Prior to that, Yoko worked at Eli Lilly and Company from 1999 to 2007 in clinical research and project management roles. They also briefly served as a Manager in R&D at Genzyme, a Sanofi company, in 2010–2011. Yoko is pursuing a Bachelor of Science and a Master of Science at Kobe University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices